The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mortality and readmission rates post CAR-T cell therapy in relapsed/refractory multiple myeloma: Real-world, multicentre, retrospective cohort study using TriNetX database.
 
Kanika Goyal
No Relationships to Disclose
 
Nikhil Vojjala
No Relationships to Disclose
 
Deevyashali Parekh
No Relationships to Disclose
 
Avi Harisingani
No Relationships to Disclose
 
Adit Dharia
No Relationships to Disclose
 
Rishab Prabhu
No Relationships to Disclose
 
Srijan Valasapalli
No Relationships to Disclose
 
Shajadi Patan
Stock and Other Ownership Interests - PDS Biotechnology (I)
Travel, Accommodations, Expenses - Aptitude Health
 
Joseph McGuirk
Employment - University of Kansas Health System
Leadership - University of Kansas Cancer Center
Honoraria - AlloVir; Autolus; Bristol-Myers Squibb/Sanofi; CARGO Therapeutics; crispr therapeutics; Kite, a Gilead company; Legend Biotech; Nektar; Novartis; Sana Biotechnology
Consulting or Advisory Role - Allovir; crispr therapeutics; EcoR1 Capital; Fosun Kite Biotechnology Co., Ltd.; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics; Nektar; Novartis; Sana Biotechnology, Inc.; Sanofi US Services, Inc.
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; SITC/ACCC; Syncopation Life Sciences
 
Nausheen Ahmed
Consulting or Advisory Role - BMS; Invivyd; Kite/ Gilead; Legend Biotech
Research Funding - Kite/Gilead (Inst)